Subsequent analysis showed that vascular endothelial growth factor (VEGF) was the most differentially expressed gene between high-diversity and low-diversity groups, especially in cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and tumor-associated endothelial cells (TECs). This evidence concerns the gene VEGFA and neoplasm.